One important note: this combination does not affect cortisol or prolactin levels, which is relevant for menopausal women who may already be dealing with cortisol dysregulation
Use this as a reference point, then read the deeper sections below for the full picture
The average weight loss with GLP-1 medications can differ based on the specific product and the individual
A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
Rather than issuing clinical recommendations, this approach delineates where renal evidence is most robust, where it is heterogeneous, and where important gaps persist, thereby supporting interpretation and future appropriateness deliberations
One of the most common physiological changes seen is the depletion of the body's most powerful antioxidant, reduced glutathione